Variant report
Variant | esv2763557 |
---|---|
Chromosome Location | chr6:65164091-65187974 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PHF3-10 | chr6:65179250-65179393 | NONHSAT113362 |
2 | lnc-PHF3-10 | chr6:65166930-65167043 | NONHSAT113362 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567232103 | chr6:65166974-65166975 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs28445464 | chr6:65169260-65169261 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs555354361 | chr6:65169311-65169312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189233307 | chr6:65169341-65169342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544180727 | chr6:65169342-65169343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146261890 | chr6:65169347-65169348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192198745 | chr6:65169383-65169384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533070487 | chr6:65169499-65169500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545238136 | chr6:65169554-65169555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560043224 | chr6:65169566-65169567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559214999 | chr6:65179264-65179265 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs577540942 | chr6:65179307-65179308 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs183548346 | chr6:65179324-65179325 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs541622505 | chr6:65179331-65179332 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs141413599 | chr6:65185922-65185923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559099217 | chr6:65185952-65185953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577414912 | chr6:65185961-65185962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs3846796 | chr6:65186006-65186007 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs562174266 | chr6:65186145-65186146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs147002065 | chr6:65186157-65186158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541780913 | chr6:65186174-65186175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189241403 | chr6:65186244-65186245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530626683 | chr6:65186299-65186300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116341884 | chr6:65186314-65186315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547624741 | chr6:65186316-65186317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374316622 | chr6:65186335-65186336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs59130430 | chr6:65186352-65186353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546606580 | chr6:65186373-65186374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567939150 | chr6:65186418-65186419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535397893 | chr6:65186427-65186428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554752983 | chr6:65186428-65186429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57162120 | chr6:65186441-65186442 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs570318822 | chr6:65186468-65186469 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116650019 | chr6:65186469-65186470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192205152 | chr6:65186602-65186603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147644943 | chr6:65186643-65186644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577448532 | chr6:65186686-65186687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534785675 | chr6:65186770-65186771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs9351272 | chr6:65186776-65186777 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs9345146 | chr6:65186828-65186829 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs558427207 | chr6:65186908-65186909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542166137 | chr6:65186976-65186977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563243120 | chr6:65187010-65187011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142125307 | chr6:65187035-65187036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545631550 | chr6:65187045-65187046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9342288 | chr6:65187046-65187047 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs528215570 | chr6:65187078-65187079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546395595 | chr6:65187083-65187084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs16895250 | chr6:65187148-65187149 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs368111734 | chr6:65187211-65187212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65169200-65169600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr6:65185800-65187800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr6:65186000-65186200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:65186200-65187200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr6:65186600-65188000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr6:65187000-65188000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr6:65187200-65188000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |